![]() |
|
The Need for 3rd-Line Therapy in Non-Small Cell Lung Cancer Frances A. Shepherd, MD Scott Taylor Chair in Lung Cancer Research Princess Margaret Hospital
3894S1_01_2- AstraZeneca-Refractory-NSCLC .ppt - Search
3rd-line
therapy
non-small
frances
scott
taylor
chair
cancer
research
princess
margaret
Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small Cell Lung Cancer Stage IV NSCLC slide set. www.asco.org/guidelines/nsclc.
Targeting NSCLC in the future Lucio Crinò Silvestrini Hospital Perugia, Italy Targeting NSCLC in the future: approaches to further optimise treatment strategies Will ...
Targeting in the future.ppt - Search
targeting
future
lucio
silvestrini
hospital
italy
approaches
further
optimise
treatment
strategies
Non-small cell lung cancer, version 1 2007. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf Tarceva monotherapy or chemotherapy (docetaxel or ...
SMALL CELL LUNG CANCER (SCLC) and TKIs in NSCLC . G. Giaccone. Chief Medical Oncology Branch. National Cancer Institute. Bethesda, Maryland
Tobacco Use in the USA 1900-1999 . Per capita cigarette consumption . Male lung cancer death rate . Female lung cancer death rate *Age-adjusted to 2000 US standard ...
Updates in Metastatic Non-small Cell Lung Cancer: Biomarkers and Targeted Therapy . James Stevenson, MD. Ivan Damjanov, MD, PhD. Scott Cowan, MD
Elderly Patients with Advanced NSCLC: Emerging Role of Targeted Therapy . Corey J Langer MD, FACP. Professor of Medicine. Director of Thoracic Oncology
ADVANCED NSCLC Special Populations PS 2 Elderly Corey J. Langer, M.D. Co-Director, Thoracic Oncology Fox Chase Cancer Center Philadelphia, PA 19111
Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small Cell Lung Cancer * * * * * * * * * * * * * * * * * * Special Announcement The US Food and ...
Multimodality treatment of stage III NSCLC . Jan P van Meerbeeck. EIS-Geneva . March 31, 2007
CI-1 . IRESSA ® (ZD1839) Monotherapy for Non-Small Cell Lung Cancer (NSCLC) Oncologic Drugs . Advisory Committee Meeting. September 24, 2002
Patient Case Discussion Advanced NSCLC Robert Pirker Medical University of Vienna . ESMO International Symposium on Chest Tumors. Geneva, 30.3.-1.4.2007
LCT10000711.ppt - Search
patient
discussion
robert
pirker
university
vienna
international
symposium
chest
Stage I Lung Radiosurgery: Overview, Results, and Current RTOG Studies Douglas Johnson, MD, FACR Florida Radiation Oncology Group ACRIN Sept 2010 Annual Meeting
Cytotoxic Chemotherapy Produces Limited Benefit in Stage IV NSCLC All recent randomized chemotherapy studies have similar results Median survival: 8 mo
1797.03_2.ppt - Search
cytotoxic
chemotherapy
produces
limited
benefit
recent
randomized
studies
similar
results
median
Adjuvant chemotherapy in stage IB non-small cell lung cancer: update of cancer and leukemia group B (CALGB) protocol 9633. [Abstract 7007]. Journal of Clinical Oncology ...
Studies in NSCLC Based on Gender and Smoking Differences: Rationale and Outcomes Silvia Novello University of Turin Thoracic Oncology Unit
Medically inoperable patients with early-stage non-small cell lung cancer . Locally recurrent: confined to chest . 5-yrs S.V 5-15% ( R/T alone )
... Carcinoma of Lung Also called undifferentiated or oat cell carcinoma Accounts for 10-15% of lung tumors Almost always caused by smoking Fast growing compared to NSCLC ...
RLLungCancerMunireddy0608.ppt - Search
carcinoma
called
undifferentiated
accounts
tumors
almost
always
caused
growing
compared
... Winton et al: A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non small cell lung cancer (NSCLC ...
|
Hot Documents stresshormoneenergie-thermique semiconductors anaerobik sondes seleccion-de-proveedores anelidos el-ahogado-mas-hermoso-del-mundo zelengrada presentacion_estudio-final |